(MENAFN- iCrowdNewsWire)Urinary incontinence can have a debilitating impact on a patient’s quality of life and individuals suffering from it are treated by a diverse range of health care professionals ...

The FDA has cleared InTone, a medical device for treating female urinary incontinence. InTone is the first medical device that combines mild micro-current stimulation (similar to a transcutaneous ...

The majority of adult women in the US suffer urinary incontinence (UI), with the most common form of UI being Stress Urinary Incontinence (SUI), which is often caused by weak pelvic floor muscles. SUI ...

Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...

Please provide your email address to receive an email when new articles are posted on . A digital intravaginal device for pelvic floor muscle training improved urinary incontinence symptoms and ...

Company is Poised to Participate in $4B U.S. Adult Urinary Incontinence Market EDMOND, Okla., May 17, 2024 /PRNewswire/ -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops ...

Axena, a medical device company focused on female health, has closed on an additional $9.4 million in its Series A fundraising. From Boston Inno. A Newton, Mass.-based startup dedicated to women's ...

Relief Srl raised more than €1 million (US$1.08 million) in financing for Urorelief, its endourethral medical device which treats stress urinary incontinence. The Italian startup will use the funds to ...

Urinary Incontinence Devices Market By Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), By Type (External Devices, Internal Devices) ...

Urinary incontinence or bladder leakage occurs when urine (pee) comes out of your bladder when you do not want it to (involuntarily). It is more common in women for the following reasons: ...

MINNEAPOLIS--(BUSINESS WIRE)--Uromedica, Inc. announces the initiation of its FDA Investigational Device Exemption trial for ACT® to evaluate its safety and efficacy for treatment of female SUI.

Each older adult’s life experience is unique, as is each person’s experience with UI. Effective treatment requires a multifaceted approach that focuses on the level of patient understanding and the ...